Literature DB >> 24799972

A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia.

Haifaa Dbouk1, Simon Mentha2, Deborah Mukherji1, Jean Lee2, Ali Haydar1, Ali Shamseddine1, Eileen M O'Reilly3, Leonard Saltz3, Ghassan K Abou-Alfa3.   

Abstract

Entities:  

Year:  2014        PMID： 24799972      PMCID： PMC4007677     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  20 in total

1.  Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors:  Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

Review 2.  Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Authors:  Marnelli A Bautista; W Tait Stevens; Chien-Shing Chen; Brian R Curtis; Richard H Aster; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2010-03-26       Impact factor: 17.388

3.  Rifampicin-dependent antibodies bind a similar or identical epitope to glycoprotein IX-specific quinine-dependent antibodies.

Authors:  J K Burgess; J A Lopez; L E Gaudry; B H Chong
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

4.  A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis.

Authors:  Carla Hajj; Karyn Goodman; David Kelsen; Jinru Shia; Ali Shamseddine; Mohamed Naghy; Mustafa Sidani; Mohamed Eloubeidi; Fady Merhi; Fady Geara; Celina Ang; Leonard Saltz; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-05

5.  Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.

Authors:  R K Ramanathan; M L Rothenberg; A de Gramont; C Tournigand; R M Goldberg; S Gupta; T André
Journal:  Ann Oncol       Date:  2009-11-03       Impact factor: 32.976

6.  Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

Authors:  Michael J Overman; Dipen M Maru; Chusilp Charnsangavej; Evelyn M Loyer; Huamin Wang; Priyanka Pathak; Cathy Eng; Paulo M Hoff; Jean-Nicolas Vauthey; Robert A Wolff; Scott Kopetz
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

7.  FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

Authors:  Christophe Tournigand; Thierry André; Emmanuel Achille; Gérard Lledo; Michel Flesh; Dominique Mery-Mignard; Emmanuel Quinaux; Corinne Couteau; Marc Buyse; Gérard Ganem; Bruno Landi; Philippe Colin; Christophe Louvet; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2003-12-02       Impact factor: 44.544

8.  Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.

Authors:  David Gammon; Pankaj Bhargava; Michael J McCormick
Journal:  Oncologist       Date:  2004

9.  Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex.

Authors:  B R Curtis; J G McFarland; G G Wu; G P Visentin; R H Aster
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113

Review 10.  Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.

Authors:  Charlotte S van Kessel; Constantinus F M Buckens; Maurice A A J van den Bosch; Maarten S van Leeuwen; Richard van Hillegersberg; Helena M Verkooijen
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.